31/05/2026
๐๐ข๐ ๐ฌ๐ญ๐๐ฉ ๐๐จ๐ซ๐ฐ๐๐ซ๐ ๐๐จ๐ซ ๐๐๐ง๐๐๐ซ ๐๐๐ซ๐ ๐จ๐ง ๐ญ๐ก๐ ๐๐๐!
๐ A new 1-minute immunotherapy injection is being rolled out across England for thousands of cancer patients each year (around 14,000).
The treatment replaces lengthy IV infusions with a quick under-the-skin jab for eligible patients receiving pembrolizumab (Keytruda), helping reduce time spent in hospital while freeing up NHS capacity.
The jab can be used across 14 different cancer types, including lung, breast, bowel, cervical and skin cancers.
๐ฅ Faster treatment. More convenience for patients. More capacity for care.
๐ซถ A great example of innovation making a real difference to patient experience and healthcare delivery.